Surgical management of bisphosphonate induced osteonecrosis of the jaws

International Journal of Oral and Maxillofacial Surgery

Volumn 39, Issue 3, 2010, Pages 251-255

  Williamson, R A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

bisphosphonate; jaws; management; osteonecrosis; surgical

Indexed keywords

AMOXICILLIN; BISPHOSPHONIC ACID DERIVATIVE; CHLORHEXIDINE; CLINDAMYCIN; PENICILLIN G;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE CANCER; BONE DESTRUCTION; CANCER THERAPY; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DEBRIDEMENT; FEMALE; HUMAN; JAW OSTEONECROSIS; MALE; MULTIPLE MYELOMA; OSTEOPOROSIS; PATIENT ASSESSMENT; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; CHLORHEXIDINE; CLINDAMYCIN; DEBRIDEMENT; DIPHOSPHONATES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAW DISEASES; MALE; MIDDLE AGED; MOUTHWASHES; MULTIPLE MYELOMA; OSTEONECROSIS; OSTEOPOROSIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURGICAL FLAPS; SUTURE TECHNIQUES; TREATMENT OUTCOME;

EID: 77549083145     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2009.11.014     Document Type: Article

References (14)

1. American Dental Association Council on Scientific Affairs. Expert panel recommendations: dental management of patients receiving oral bisphosphonate therapy. J Am Dental Assoc 137 (2006) 1144-1150
2. Badros A., Weikel D., Salama A., Goloubeva O., Schneider A., Rapoport A., Fenton R., Gahres N., Sausville E., Ord R., and Meiller T. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 24 February (6) (2006) 945-952
3. Carter G.D., and Goss A.N. Bisphosphonates and avascular necrosis of the jaws. Aust Dent J 48 (2003) 268
4. Cheng A., Mavrokokki A., Carter G., Stein B., Fazzalari N.L., Wilson D.F., and Goss A.N. The dental implications of bisphosphonates and bone disease. Aust Dent J 50 (4) Suppl. 2 (2005) S4-13
5. Durie B.G., Katz M., and Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353 (2005) 99-102
6. Hortobagyi G.N., Theriault R.L., Lipton A., Porter L., Blayney D., Sinoff C., Wheeler H., Simeone J.F., Seaman J.J., Knight R.D., Heffernan M., Mellars K., and Reitsma D.J. Long-term prevention of skeletal complications of metastatic breast cancer with pamidrounate. Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol 16 (1998) 2038-2044
7. Kademani D., Kora S., Lacy M.Q., and Rajkumar S.V. Surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy. Mayo Clin Proc 81 8 (2006) 100-1103
8. Marx R.E. Pamidronate (Aredia) and Zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115-1117
9. Pogrel M.A. Bisphosphonates and bone necrosis. J Oral Maxillofac Surg 62 (2004) 391-392
10. Ruggiero S., Gralow J., Marx R.E., Hoff A.O., Schubert M.M., Huryn J.M., Toth B., Damato K., and Valero V. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Prac 2 January (1) (2006) 7-14
11. Ruggiero S.L., Mehrotra B., Rosenberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527-534
12. Vincenzi B., Santini D., Rocci L., and Tonini G. Bisphosphonates: new antiangiogenic molecules in cancer treatment?. Ann Oncol 14 (2003) 806-807
13. Wang J., Goodger N.M., and Pogrel M.A. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61 (2003) 1104-1107
14. Watts N.B. Bisphosphonate treatment of osteoporosis. Clin Geriatr Med 19 (2003) 395-414